Andreeff M - Search Results

1

Accumulation of cyclin B1, activation of cyclin B1-dependent kinase and induction of programmed cell death in human epidermoid carcinoma KB cells treated with taxol.

Ling YH, Consoli U, Tornos C, Andreeff M, Perez-Soler R. Ling YH, et al. Among authors: andreeff m. Int J Cancer. 1998 Mar 16;75(6):925-32. doi: 10.1002/(sici)1097-0215(19980316)75:6<925::aid-ijc16>3.0.co;2-1. Int J Cancer. 1998. PMID: 9506539 Free article.

2

Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid.

Drach J, Lopez-Berestein G, McQueen T, Andreeff M, Mehta K. Drach J, et al. Among authors: andreeff m. Cancer Res. 1993 May 1;53(9):2100-4. Cancer Res. 1993. PMID: 8481912

3

Activation of p21WAF1/Cip1 expression by a temperature-sensitive mutant of human p53 does not lead to apoptosis.

Kobayashi T, Consoli U, Andreeff M, Shiku H, Deisseroth AB, Zhang W. Kobayashi T, et al. Among authors: andreeff m. Oncogene. 1995 Dec 7;11(11):2311-6. Oncogene. 1995. PMID: 8570182

4

A pilot study of high-dose interleukin-3 treatment of relapsed follicular small cleaved-cell lymphoma: hematologic, immunologic, and clinical results.

Younes A, Sarris A, Consoli U, Rodriguez A, McLaughlin P, Huh Y, Starry S, Cabanillas F, Andreeff M. Younes A, et al. Among authors: andreeff m. Blood. 1996 Mar 1;87(5):1698-703. Blood. 1996. PMID: 8634414 Free article. Clinical Trial.

5

Myeloid markers in adult acute lymphocytic leukemia. Correlations with patient and disease characteristics and with prognosis.

Preti HA, Huh YO, O'Brien SM, Andreeff M, Pierce ST, Keating M, Kantarjian HM. Preti HA, et al. Among authors: andreeff m. Cancer. 1995 Nov 1;76(9):1564-70. doi: 10.1002/1097-0142(19951101)76:9<1564::aid-cncr2820760911>3.0.co;2-1. Cancer. 1995. PMID: 8635059

6

CD30 ligand is expressed on resting normal and malignant human B lymphocytes.

Younes A, Consoli U, Zhao S, Snell V, Thomas E, Gruss HJ, Cabanillas F, Andreeff M. Younes A, et al. Among authors: andreeff m. Br J Haematol. 1996 Jun;93(3):569-71. doi: 10.1046/j.1365-2141.1996.d01-1686.x. Br J Haematol. 1996. PMID: 8652374

7

The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines.

Consoli U, Priebe W, Ling YH, Mahadevia R, Griffin M, Zhao S, Perez-Soler R, Andreeff M. Consoli U, et al. Among authors: andreeff m. Blood. 1996 Jul 15;88(2):633-44. Blood. 1996. PMID: 8695811 Free article.

8

Semi-automated PCR method for quantitating MDR1 expression.

Zhao S, Consoli U, Arceci R, Pfeifer J, Dalton WS, Andreeff M. Zhao S, et al. Among authors: andreeff m. Biotechniques. 1996 Oct;21(4):726-31. doi: 10.2144/96214pf01. Biotechniques. 1996. PMID: 8891227 Free article.

9

Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax.

Lisovsky M, Estrov Z, Zhang X, Consoli U, Sanchez-Williams G, Snell V, Munker R, Goodacre A, Savchenko V, Andreeff M. Lisovsky M, et al. Among authors: andreeff m. Blood. 1996 Nov 15;88(10):3987-97. Blood. 1996. PMID: 8916965 Free article.

10

Annamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposide.

Perez-Soler R, Neamati N, Zou Y, Schneider E, Doyle LA, Andreeff M, Priebe W, Ling YH. Perez-Soler R, et al. Among authors: andreeff m. Int J Cancer. 1997 Mar 28;71(1):35-41. doi: 10.1002/(sici)1097-0215(19970328)71:1<35::aid-ijc8>3.0.co;2-4. Int J Cancer. 1997. PMID: 9096663 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

786 results

Search Page